NIR Spectroscopy
IndustriesPharma & Biopharma
ManufacturerMetrohm
Significance of the Topic
Dissolution testing of solid dosage forms is essential for ensuring consistent drug release and therapeutic effect. Conventional methods can be time consuming and destructive, especially for sustained release tablets requiring up to twenty four hours of testing. Near infrared spectroscopy offers rapid, nondestructive prediction of dissolution profiles, aligning with Process Analytical Technology initiatives and reducing laboratory workload.
Objectives and Study Overview
This study aimed to develop and validate a near infrared based predictive model for the dissolution profile of intact sustained release propranolol tablets. Tablets formulated with varying levels of the plasticizer acetyltributyl citrate were analyzed to assess the NIR ability to forecast percentage drug release at multiple time points between one and twenty four hours.
Methodology and Used Instrumentation
Tablet Formulation
- Propranolol tablets with ethylcellulose matrix and ATBC levels of 0, 6, 8 and 10 percent
- Compression on Elizabeth Hata rotary tablet press
NIR Spectroscopy
- Instrument NIRS XDS MasterLab with transmission measurement
- Wavelength range 800 to 1650 nanometers at 0.5 nanometer intervals
- Scanning configuration 32 co-added scans per tablet, thirty one tablets in under ten minutes
Chemometric Modeling
- Pretreatment using second derivative transformation, smoothing and standard normal variate correction
- Partial least squares regression with seven latent factors selected by minimizing the predicted residual error sum of squares
- Development of fourteen individual PLS1 models for time points from one to twenty four hours
Results and Discussion
The PLS models demonstrated excellent calibration and validation performance. For the one hour time point the model achieved R2 of 0.997 and standard error of cross validation of 0.422. Twelve and twenty four hour predictions also showed R2 values above 0.978 with acceptable errors. Model predictions closely matched laboratory dissolution data across differing ATBC levels, confirming that NIR can accurately forecast release profiles of intact tablets.
Benefits and Practical Application
- Non destructive analysis preserves samples for further testing
- Rapid throughput with thirty one tablets in less than ten minutes
- Reduces reliance on lengthy traditional dissolution apparatus
- Supports FDA PAT initiatives and 21 CFR part 11 compliant reporting
- Potential integration into production lines for real time release testing
Future Trends and Potential Applications
- Extension of NIR models to other formulations and active ingredients
- Implementation of inline or atline sensors for continuous quality monitoring
- Combination with advanced multivariate algorithms and machine learning to enhance robustness
- Integration into Quality by Design frameworks to optimize formulation and process control
Conclusion
This application note demonstrates that near infrared spectroscopy combined with chemometric modeling provides a fast and accurate approach to predict dissolution profiles of intact sustained release tablets. The methodology can streamline quality control, reduce laboratory burden and support real time release strategies in pharmaceutical manufacturing.
References
- M Blanco et al Non destructive dissolution testing by NIR spectroscopy September 2007 Vol 18 No 6
- R Fahmy Quality by Design Application of NIR Spectroscopy for Formulation Development of Sustained Release Dosage Forms Presentation FDA Center of Veterinary Medicine University of Maryland
- RA Mattes et al Near Infrared Assay and Content Uniformity of Tablets Pharmaceutical Technology 4 2007
- R Kramer Chemometric Techniques for Quantitative Analysis Marcel Dekker 1998
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.